Live Breaking News & Updates on Chief Executive Officer Vas Narasimhan

Stay updated with breaking news from Chief executive officer vas narasimhan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novartis Raises Forecast as Sales of New Blockbusters Climb

Novartis Raises Forecast as Sales of New Blockbusters Climb
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Giovanni Caforio , Joerg Reinhardt , Bristol Myers Squibb Co , Roche Holding , Chief Executive Officer Vas Narasimhan , Bristol Myers Squibb , Swiss Pharma Giants Plot Different Paths , Next Blockbusters ,

Novartis Surges After Forecast Boost Beats Expectations

Novartis Surges After Forecast Boost Beats Expectations
swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.

Harry Kirsch , Giovanni Caforio , Joerg Reinhardt , Peter Welford , Bristol Myers Squibb Co , Chief Financial Officer Harry Kirsch , Chief Executive Officer Vas Narasimhan , Bristol Myers Squibb , Swiss Pharma Giants Plot Different Paths , Next Blockbusters ,

Big Pharma Targets Smaller Companies With Megadeals Out of Favor

Big Pharma Targets Smaller Companies With Megadeals Out of Favor
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Emma Walmsley , Wouter Joustra , Alcon Inc , Pfizer Inc , Jpmorgan Health Conference , Eli Lilly Co , Sandoz Group , Haleon Plc , Ambrx Biopharma Inc , Aiolos Bio Inc , Amgen Inc , Inhibrx Inc , Ambrx Biopharma , Aiolos Bio , Biotech Deal Surge Dials Up Buzz , Horizon Therapeutics , Chief Executive Officer Vas Narasimhan ,

Novartis Shares Drop on Weak Prostate Cancer Drug Sales

Novartis AG shares slumped after the drugmaker reported earnings that came short of analysts’ estimates on weak revenue from Pluvicto, a prostate cancer treatment that faced supply constraints. ....

James Cone , Guy Johnson , Kriti Gupta , Intron Health , Roche Holding , Bloomberg Television , Medicines Co , Chief Executive Officer Vas Narasimhan , Swiss Pharma Giants Plot Different Paths , Next Blockbusters , Novartis Ag , Prostate Cancer Treatment ,